← back to search

Timothy P. Stinear

The University of Melbourne · AU
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Mycobacterium research and diagnosis, Antimicrobial Resistance in Staphylococcus, Tuberculosis Research and Epidemiology, and Infectious Diseases and Mycology.
h-index
76
citations
19,756
works
506
NIH funding
primary concept
email

Recent publications

Staphylococcus aureus adapts to exploit collagen-derived proline during chronic infection
Nature Microbiology 2024cited by 24position: middledoi
Buruli ulcer in Australia: Evidence for a new endemic focus at Batemans Bay, New South Wales
PLoS neglected tropical diseases 2024cited by 4position: middledoi
Staphylococcus aureus host interactions and adaptation
Nature Reviews Microbiology 2023cited by 641position: lastdoi
Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria
Nature Communications 2023cited by 60position: middledoi
Global analysis of biosynthetic gene clusters reveals conserved and unique natural products in entomopathogenic nematode-symbiotic bacteria
Nature Chemistry 2022cited by 113position: middledoi
Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study
The Lancet Public Health 2021cited by 80position: middledoi
Population genomics provides insights into the evolution and adaptation to humans of the waterborne pathogen Mycobacterium kansasii
Nature Communications 2021cited by 45position: middledoi
Genomic investigation of Staphylococcus aureus recovered from Gambian women and newborns following an oral dose of intra-partum azithromycin
Journal of Antimicrobial Chemotherapy 2019cited by 20position: middledoi
Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis
Nature Microbiology 2018cited by 295position: middledoi
Natural product diversity associated with the nematode symbionts Photorhabdus and Xenorhabdus
Nature Microbiology 2017cited by 196position: middledoi
Convergent Adaptation in the Dominant Global Hospital Clone ST239 of Methicillin-Resistant Staphylococcus aureus
mBio 2015cited by 125position: middledoi
The RpoB H481Y Rifampicin Resistance Mutation and an Active Stringent Response Reduce Virulence and Increase Resistance to Innate Immune Responses in Staphylococcus aureus
The Journal of Infectious Diseases 2012cited by 97position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Benjamin P. Howden · Human Growth Foundation7 papers (2012–2024)Torsten Seemann · The University of Melbourne3 papers (2015–2019)Ian R. Monk · The University of Melbourne3 papers (2018–2024)Sarah L. Baines · The University of Melbourne3 papers (2015–2023)Tania Wong Fok Lung · Columbia University2 papers (2023–2024)Jean Lee · Philadelphia College of Osteopathic Medicine2 papers (2018–2023) · 2 papers (2021–2024) · 2 papers (2021–2024)Anders Gonçalves da Silva · Monash University2 papers (2018–2019)Mark B. Schultz · Gas- und Wärme-Institut Essen2 papers (2015–2019) · 2 papers (2017–2022)Peter Grün · Max Planck Institute for Terrestrial Microbiology2 papers (2017–2022)Yi‐Ming Shi · Goethe University Frankfurt2 papers (2017–2022)Helge B. Bode · Loewe Center for Synthetic Microbiology2 papers (2017–2022)Nicholas J. Tobias · The University of Melbourne2 papers (2017–2022)Andreacarola Urso · Columbia University1 papers (2024–2024)Svenja Simonyi · Goethe University Frankfurt1 papers (2017–2017) · 1 papers (2019–2019)Ingo Ebersberger · Goethe University Frankfurt1 papers (2017–2017)J. M. Boylan · Columbia University1 papers (2024–2024)